Quote:

---

If the Chinese want to use Leronlimab for the coronavirus, I imagine they’ll move to close the deal faster than Vyera.

---

Considering they have already submitted safety and efficacy data for leronlimab to the CFDA, that looks to be the plan. I don't think it will be one of those situation where we wait years for a slow moving FDA to decide on exactly how many patients and which dose they did for safety data. I imagine with China in panic mode with coronavirus, if it works, it will be moved through at lightning speed, given they have already started by submitting data to the CFDA. At this point, I believe it working for them is more important than the cost. I could imagine this being approved in China quickly this year before the US, again if it is successful in the trail. JMO.